Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Ionis Pharmaceuticals's peak revenue was $1.1B in 2019. The peak quarterly revenue was $493.7M in 2019(q4).
Ionis Pharmaceuticals's revenue increased from $121.6m in 2009 to $705.1M currently. That's a 479.88% change in annual revenue.
| Fiscal year / year | Ionis Pharmaceuticals revenue |
|---|---|
| 2009 | $121.6M |
| 2010 | $108.5M |
| 2011 | $99.1M |
| 2012 | $102.0M |
| 2013 | $147.3M |
| 2014 | $214.2M |
| 2015 | $283.7M |
| 2016 | $346.6M |
| 2017 | $507.7M |
| 2018 | $599.7M |
| 2019 | $1.1B |
| 2020 | $729.3M |
| 2021 | $810.5M |
| 2022 | $587.4M |
| 2023 | $787.6M |
| 2024 | $705.1M |
Rate Ionis Pharmaceuticals' financial transparency
Ionis Pharmaceuticals saw the greatest revenue growth in 2019, when revenue increased by 87.2%.
Ionis Pharmaceuticals had the lowest revenue growth in 2020, when revenue changed by -35.04%.
| Year | Ionis Pharmaceuticals growth |
|---|---|
| 2010 | -11%↓ |
| 2011 | -9%↓ |
| 2012 | 3%↑ |
| 2013 | 44%↑ |
| 2014 | 45%↑ |
| 2015 | 32%↑ |
| 2016 | 22%↑ |
| 2017 | 46%↑ |
| 2018 | 18%↑ |
| 2019 | 87%↑ |
| 2020 | -35%↓ |
| 2021 | 11%↑ |
| 2022 | -28%↓ |
| 2023 | 34%↑ |
| 2024 | -10%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2010 | - | $23.5M | $28.6M | $26.4M |
| 2011 | $21.1M | $24.8M | $20.7M | $32.4M |
| 2012 | $23.2M | $47.3M | $11.6M | $19.9M |
| 2013 | $43.4M | $38.1M | $23.6M | $42.2M |
| 2014 | $28.2M | $57.1M | $44.1M | $84.9M |
| 2015 | $62.6M | $120.4M | $49.1M | $51.6M |
| 2016 | $36.9M | $38.5M | $110.9M | $186.6M |
| 2017 | $115.8M | $112.3M | $118.3M | $161.3M |
| 2018 | $144.4M | $117.7M | $145.4M | $192.1M |
| 2019 | $297.2M | $163.8M | $167.9M | $493.7M |
| 2020 | $133.4M | $145.5M | $160.1M | $290.3M |
| 2021 | $111.6M | $125.8M | $133.1M | $440.0M |
| 2022 | $141.9M | $133.8M | $159.8M | $151.9M |
| 2023 | $130.5M | $188.4M | $144.2M | $324.5M |
| 2024 | $119.5M | $225.3M | $133.8M | $226.6M |
Do you work at Ionis Pharmaceuticals?
Did Ionis Pharmaceuticals meet its revenue projections?
| CEO | Stanley Crooke |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 817 |
| Date Founded | 1989 |
| Headquarters | Carlsbad, California |
| Number of Locations | 1 |
| Revenue | $705.1M |
| Net Income | -$269,722,000 |
| Gross Proft | $693.9M (2024) |
| PE Ratio | -15.57 |
| Tax Rate | 0.0% |
| Market Capitalization | $7.1B |
| Total Assets | $2,533,876,000 |
| Ticker | IONS |
Ionis Pharmaceuticals received early financing of $201.3M on 2012-08-27.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Debt | $201.3M | 08/2012 |
| Post Ipo Debt | $550M | 04/2021 |
Zippia gives an in-depth look into the details of Ionis Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ionis Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Ionis Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ionis Pharmaceuticals. The data presented on this page does not represent the view of Ionis Pharmaceuticals and its employees or that of Zippia.
Ionis Pharmaceuticals may also be known as or be related to Ionis Pharmaceuticals, Ionis Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Ionis Pharmaceuticals, Inc. and Isis Pharmaceuticals Inc.